GE HealthCare reports second quarter 2025 financial results

GE HealthCare reports second quarter 2025 financial results

GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025.…

Continue Reading
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
GE HealthCare reports third quarter 2024 financial results

GE HealthCare reports third quarter 2024 financial results

GE HealthCare (GEHC) reported Q3 2024 financial results with revenues of…

Continue Reading
GE HealthCare reports third quarter 2024 financial results

GE HealthCare announces cash dividend for third quarter of 2024

GE HealthCare Technologies Inc. (Nasdaq: GEHC) has announced a cash dividend…

Continue Reading
Viemed Healthcare Announces Record Second Quarter 2024 Financial Results

Viemed Healthcare Announces Record Second Quarter 2024 Financial Results

Viemed Healthcare, Inc. LAFAYETTE, La., Aug. 07, 2024 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company”…

Continue Reading
GE HealthCare stock falls 14% after release of its first quarter earnings

GE HealthCare stock falls 14% after release of its first quarter earnings

GE HealthCare announced essentially flat organic growth in the first quarter of this year compared to…

Continue Reading